HCTI vs VEEV

For growth investors, Veeva Systems Inc.

(VEEV) is the stronger pick with 16. 3% revenue growth year-over-year, versus -64. 8% for Healthcare Triangle, Inc. (HCTI). Veeva Systems Inc. (VEEV) offers the better valuation at 30. 9x trailing P/E (18. 8x forward), making it the more compelling value choice. Analysts rate Veeva Systems Inc. (VEEV) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Veeva Systems Inc.

(VEEV) delivered a total return of -35. 3%, compared to -100. 0% for Healthcare Triangle, Inc. (HCTI). Over 10 years, the gap is even starker: VEEV returned +512. 1% versus HCTI's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Veeva Systems Inc.

(VEEV) is the lower-risk stock at 0. 72β versus Healthcare Triangle, Inc. 's 3. 25β — meaning HCTI is approximately 349% more volatile than VEEV relative to the S&P 500.

By revenue growth (latest reported year), Veeva Systems Inc.

(VEEV) is pulling ahead at 16. 3% versus -64. 8% for Healthcare Triangle, Inc. (HCTI). On earnings-per-share growth, the picture is similar: Healthcare Triangle, Inc. grew EPS 45. 6% year-over-year, compared to 25. 9% for Veeva Systems Inc.. Over a 3-year CAGR, VEEV leads at 14. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Veeva Systems Inc.

(VEEV) is the more profitable company, earning 28. 4% net margin versus -51. 0% for Healthcare Triangle, Inc. — meaning it keeps 28. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VEEV leads at 28. 7% versus -40. 6% for HCTI. At the gross margin level — before operating expenses — VEEV leads at 75. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Veeva Systems Inc.

(VEEV) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), +512. 1% 10Y return). Healthcare Triangle, Inc. (HCTI) carries a higher beta of 3. 25 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VEEV: +512. 1%, HCTI: -100. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HCTI is a small-cap quality compounder stock; VEEV is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.